Calcimimetic (Cinacalcet) versus conventional treatment of secondary hyperparathyroidism in children with end-stage renal disease on regular hemodialysis /
Mohamed Salah Ali Mohamed Ghonaim
Calcimimetic (Cinacalcet) versus conventional treatment of secondary hyperparathyroidism in children with end-stage renal disease on regular hemodialysis / مقارنة محفزات الكالسيوم (سناكالسيت) بالعلاج التقليدى لإرتفاع هرمون الغده الجار درقيه الثانوى فى أطفال الفشل الكلوى النهائى على الاستصفاء الدموى الدورى Mohamed Salah Ali Mohamed Ghonaim ; Supervised Fatina Ibrahim Fadel , Samar M. Sabry Ahmed , Mohamed Farouk Mohamed - Cairo : Mohamed Salah Ali Mohamed Ghonaim , 2013 - 129 P. : facsimiles ; 25cm
Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Pediatrics
Kidney plays an important role in regulation of bone and mineral homeostasis, patients with chronic kidney disease (CKD) almost always have mineral and bone disorder "CKD-MDD". As CKD progresses, PTH level increases due to altered 1,25-dihydroxy vitamin D (calcitriol) metabolism, hypocalcemia and hyperphosphatemia. Control of metabolic derangements related to bone disease is one of the important goals in management of patients with CKD
Cinacalcet Hemodiafiltration Hemodialysis
Calcimimetic (Cinacalcet) versus conventional treatment of secondary hyperparathyroidism in children with end-stage renal disease on regular hemodialysis / مقارنة محفزات الكالسيوم (سناكالسيت) بالعلاج التقليدى لإرتفاع هرمون الغده الجار درقيه الثانوى فى أطفال الفشل الكلوى النهائى على الاستصفاء الدموى الدورى Mohamed Salah Ali Mohamed Ghonaim ; Supervised Fatina Ibrahim Fadel , Samar M. Sabry Ahmed , Mohamed Farouk Mohamed - Cairo : Mohamed Salah Ali Mohamed Ghonaim , 2013 - 129 P. : facsimiles ; 25cm
Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Pediatrics
Kidney plays an important role in regulation of bone and mineral homeostasis, patients with chronic kidney disease (CKD) almost always have mineral and bone disorder "CKD-MDD". As CKD progresses, PTH level increases due to altered 1,25-dihydroxy vitamin D (calcitriol) metabolism, hypocalcemia and hyperphosphatemia. Control of metabolic derangements related to bone disease is one of the important goals in management of patients with CKD
Cinacalcet Hemodiafiltration Hemodialysis